Latest News and Press Releases
Want to stay updated on the latest news?
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In Jasper To Contact Him Directly To Discuss Their Options If you...
-
LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
-
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – JSPR
-
LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Jasper Therapeutics, Inc., (“Jasper” or the "Company") (NASDAQ: JSPR) investors of a class action on behalf of investors...
-
The complaint allegedly claims Jasper misled investors about its manufacturing controls, overstating briquilimab’s prospects and overall business outlook.
-
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
-
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options If you purchased or...
-
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – JSPR